Literature DB >> 1486866

Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology.

F P Guengerich1, T Shimada, K D Raney, C H Yun, D J Meyer, B Ketterer, T M Harris, J D Groopman, F F Kadlubar.   

Abstract

A number of different approaches have been used to determine the catalytic selectivity of individual human enzymes toward procarcinogens. Studies with cytochrome P450 (P450) enzymes and glutathione S-transferases are summarized here, and recent work with pyrrolizidine alkaloids, aflatoxins, 4,4'-methylenebis(2-chloroaniline), and ethyl carbamate is discussed. In some cases a single enzyme can catalyze both activation and detoxication reactions of a chemical. The purification and characterization of human lung P4501A1 and the development of a noninvasive assay for human P4502E1 are also described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486866      PMCID: PMC1519604          DOI: 10.1289/ehp.929875

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  24 in total

1.  Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.

Authors:  D E Williams; R L Reed; B Kedzierski; G A Dannan; F P Guengerich; D R Buhler
Journal:  Drug Metab Dispos       Date:  1989 Jul-Aug       Impact factor: 3.922

Review 2.  Enzymatic activation of chemicals to toxic metabolites.

Authors:  F P Guengerich; D C Liebler
Journal:  Crit Rev Toxicol       Date:  1985       Impact factor: 5.635

3.  Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases.

Authors:  M A Butler; F P Guengerich; F F Kadlubar
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

4.  Involvement of the exocyclic amino group of deoxyguanosine in DNA-catalysed carcinogen detoxification.

Authors:  M C MacLeod; K L Zachary
Journal:  Carcinogenesis       Date:  1985-01       Impact factor: 4.944

5.  Effects of phenobarbital on the biliary excretion of aflatoxin P1-glucuronide and aflatoxin B1-S-glutathione in the rat.

Authors:  C J Holeski; D L Eaton; D H Monroe; G M Bellamy
Journal:  Xenobiotica       Date:  1987-02       Impact factor: 1.908

6.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules.

Authors:  E C Miller; J A Miller
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

7.  Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.

Authors:  T W Kensler; P A Egner; P M Dolan; J D Groopman; B D Roebuck
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

8.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

Authors:  F P Guengerich; M V Martin; P H Beaune; P Kremers; T Wolff; D J Waxman
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

9.  Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.

Authors:  F P Guengerich
Journal:  Mol Pharmacol       Date:  1988-05       Impact factor: 4.436

10.  Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.

Authors:  T Shimada; M Iwasaki; M V Martin; F P Guengerich
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

View more
  8 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism.

Authors:  Benjamin A Rybicki; Christine Neslund-Dudas; Nora L Nock; Lonni R Schultz; Ludmila Eklund; James Rosbolt; Cathryn H Bock; Kristin G Monaghan
Journal:  Cancer Detect Prev       Date:  2006-10-25

3.  Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Authors:  Dante D Cáceres; Jeannette Iturrieta; Cristian Acevedo; Christian Huidobro; Nelson Varela; Luis Quiñones
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

Authors:  H C Liang; H Li; R A McKinnon; J J Duffy; S S Potter; A Puga; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan.

Authors:  C-A Sun; D-M Wu; L-Y Wang; C-J Chen; S-L You; R M Santella
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

6.  Spontaneous Production of Glutathione-Conjugated Forms of 1,2-Dichloropropane: Comparative Study on Metabolic Activation Processes of Dihaloalkanes Associated with Occupational Cholangiocarcinoma.

Authors:  Yu Toyoda; Tappei Takada; Hiroshi Suzuki
Journal:  Oxid Med Cell Longev       Date:  2017-05-07       Impact factor: 6.543

7.  Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.

Authors:  Angela Roco; Luis Quiñones; José A G Agúndez; Elena García-Martín; Valentina Squicciarini; Carla Miranda; Joselyn Garay; Nancy Farfán; Iván Saavedra; Dante Cáceres; Carol Ibarra; Nelson Varela
Journal:  Front Genet       Date:  2012-11-02       Impact factor: 4.599

8.  Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility.

Authors:  Amir Farmohammadi; Vahid Arab-Yarmohammadi; Ramin Ramzanpour
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.